anayamalik, Author at European Medical Journal - Page 41 of 128

How Messaging Strategies Impact STI Vaccine Uptake

Vaccine acceptance for sexually transmitted infections (STIs) may depend heavily on the way recommendations are worded, according to new cross-sectional data from the USA, China, and Indonesia.

Surgeons Confront Complex Realities in Knee Pain Care

Surgeons treating patients with unexplained pain after knee arthroplasty face profound clinical and emotional challenges, according to a new qualitative study that highlights the complexity of decision-making in this setting.

US Study Maps Shifting ITP Mortality Trends

Immune thrombocytopenic purpura (ITP) mortality in the United States has persisted over the past two decades.

Chemotherapy Choice Drives Diarrhea Risk in Anal Cancer

Acute diarrhea during chemoradiotherapy for anal cancer is significantly more likely among patients treated with 5-fluorouracil (5-FU) or capecitabine compared with those receiving cisplatin or radiotherapy alone, according to new findings.

Updated Criteria Advance Vascular Dementia Diagnosis

Revised international diagnostic criteria have been introduced for vascular cognitive impairment and dementia (VCID), aiming to standardize assessment and improve consistency across clinical and research settings.

Eosinophilic COPD Responds Best to Biologics

Biologics directed at type 2 inflammation appear to offer the most promising therapeutic option for patients with eosinophilic chronic obstructive pulmonary disease (COPD), according to a multicriteria decision analysis of clinical trials.

Nationwide Burkholderia cepacia Outbreaks Linked to Contaminated Products

Two extensive healthcare-associated outbreaks of Burkholderia cepacia complex have been reported across the United Kingdom and Ireland, highlighting the persistent risk posed by contaminated medical and hygiene products in hospital environments.

Cutaneous Vasculitis Signals Poor Outcomes in Sjögren Disease

Cutaneous vasculitis in primary Sjögren disease is linked to significantly worse outcomes, particularly when cryoglobulinemic vasculitis is present, according to findings from a large multicenter cohort study.

MARIPOSA Data Reveal Extended Survival in EGFR Lung Cancer

Overall survival in the Asia cohort of the Phase III MARIPOSA study has been reported to favor amivantamab combined with lazertinib compared with osimertinib monotherapy in patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).

Parkinson’s Linked to Distinct Gut Microbiota Patterns

Alterations in the gut microbiota are evident not only in patients with Parkinson’s disease but also in individuals with isolated REM sleep behavior disorder, suggesting that microbial changes may precede clinical onset of Parkinson’s.